Phenotypic diversity of T cells in human primary and metastatic brain tumors revealed by multiomic interrogation.
Fiche du document
- doi: 10.1038/s43018-023-00566-3
- issn: 2662-1347
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1038/s43018-023-00566-3
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/37217652
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/2662-1347
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_AF8A124C77979
info:eu-repo/semantics/openAccess , CC BY 4.0 , https://creativecommons.org/licenses/by/4.0/
Citer ce document
V. Wischnewski et al., « Phenotypic diversity of T cells in human primary and metastatic brain tumors revealed by multiomic interrogation. », Serveur académique Lausannois, ID : 10.1038/s43018-023-00566-3
Métriques
Partage / Export
Résumé
The immune-specialized environment of the healthy brain is tightly regulated to prevent excessive neuroinflammation. However, after cancer development, a tissue-specific conflict between brain-preserving immune suppression and tumor-directed immune activation may ensue. To interrogate potential roles of T cells in this process, we profiled these cells from individuals with primary or metastatic brain cancers via integrated analyses on the single-cell and bulk population levels. Our analysis revealed similarities and differences in T cell biology between individuals, with the most pronounced differences observed in a subgroup of individuals with brain metastasis, characterized by accumulation of CXCL13-expressing CD39 + potentially tumor-reactive T (pTRT) cells. In this subgroup, high pTRT cell abundance was comparable to that in primary lung cancer, whereas all other brain tumors had low levels, similar to primary breast cancer. These findings indicate that T cell-mediated tumor reactivity can occur in certain brain metastases and may inform stratification for treatment with immunotherapy.